TORONTO, April 20, 2026 /CNW/ - Today, AbbVie (NYSE: ABBV), a global research and development-based biopharmaceutical company, announced the expansion of its partnership with BioLabs by becoming the founding sponsor of the new BioLabs University of Toronto. The AbbVie and BioLabs collaboration will accelerate important life science research, with the goal of benefiting people living with serious diseases.
Read more at newswire.ca
This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.
AbbVie and BioLabs Team Up to Support Life Sciences Innovation in Canada
This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.
